Results 111 to 120 of about 4,511 (199)

Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention. [PDF]

J Mol Med (Berl)
Srikanth A, Rao RVA, Dong R, Tharehalli U, Barth TFE, Dembowsky K, Seufferlein T, Schirmbeck R, Lechel A.   +8 more
europepmc   +1 more source

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer. [PDF]

Cells
Hirayama A, Tanaka T, Ohishi T, Shinoda K, Nakamura T, Nomura A, Kojo N, Araki H, Suzuki K, Kaneko MK, Suzuki H, Kato Y.   +11 more
europepmc   +1 more source

MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer. [PDF]

Cancer Res
Pan T, Zhu J, Wang X, Tang D, Wang Z, Yang Y, Teng Y, Tian Q, Dan G, Chen C, Yu D, Liu M, Wang H, Zhang T, Guo B, Chen T, Jin B.   +16 more
europepmc   +1 more source

Harnessing the LncRNA CCAT2 role in gastric cancer: from molecular insights to clinical implications. [PDF]

Cancer Cell Int
Behzadnia A, Vanan AG, Bagheri K, Ghorbaninezhad F, Ghadyani F, Dashti M, Edrisian M, Hedayatian N, Tahmasebi S, Safarzadeh E.   +9 more
europepmc   +1 more source

Associations of inflammatory biomarkers with clinical outcomes in degenerative lumbar spinal stenosis: A systematic review. [PDF]

Brain Spine
Noma M, Djuric N, Vleggeert-Lankamp C.
europepmc   +1 more source

Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer. [PDF]

Nucl Med Commun
Oroujeni M, Selvaraju RK, Persson H, Dahllund L, Frejd FY, Mortensen ACL.   +5 more
europepmc   +1 more source

Emergence of invasive <i>Escherichia coli</i> pathobionts in gut microbiome promotes cancer stemness via targeting Hippo pathways. [PDF]

Gut Microbes
Yu LC, Wei SC, Lin BR, Li YH, Liao YC, Peng YW, Lin CH, Hu PT, Pai YC, Lai LC, Chen YT, Huang CY, Jeng YM, Ni YH.   +13 more
europepmc   +1 more source

Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management. [PDF]

Front Oncol
Almutairi WM, Zheng QH, Langer M, Oderinde OM.   +3 more
europepmc   +1 more source

CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis. [PDF]

Br J Cancer
Dong R, Srikanth A, Tharehalli U, Seufferlein T, Schirmbeck R, Lechel A.   +5 more
europepmc   +1 more source

LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein. [PDF]

Cell Mol Life Sci
Wang H, Du F, Zhang H, Li J, Xiong Q, Zhang Y, Chen N, Liu Y, Guo S, Xie Q, Dai L, Deng H.   +11 more
europepmc   +1 more source